期刊
ACS SYNTHETIC BIOLOGY
卷 9, 期 3, 页码 525-535出版社
AMER CHEMICAL SOC
DOI: 10.1021/acssynbio.9b00396
关键词
hypoxanthine; metabolic engineering; transcriptome; Escherichia coli
资金
- National Defense Science and Technology Innovation Zone Foundation of China
- National Natural Science Foundation of China [31722001, 31670089, 21807101]
- Key Program of CAS [ZDRW-ZS-2016-3M, ZDBSSSWDQC002-03]
- Natural Science Foundation of Shandong province [JQ201707]
Nucleosides and purine analogues have multiple functions in cell physiology, food additives, and pharmaceuticals, and some are produced on a large scale using different microorganisms. However, biosynthesis of purines is still lacking. In the present study, we engineered the de novo purine biosynthesis pathway, branched pathways, and a global regulator to ensure highly efficient hypoxanthine production by Escherichia coli. The engineered strain Q2973 produced 1243 mg/L hypoxanthine in fed-batch fermentation, accompanied by an extremely low accumulation of byproducts such as acetate and xanthine. We also performed global gene expression analysis to illustrate the mechanism for improving hypoxanthine production. This study demonstrated the feasibility of large-scale hypoxanthine production byan engineered E. coli strain, and provides a reference for subsequent studies on purine analogues and nucleosides.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据